These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 23628493)
1. The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis. Umbehr MH; Müntener M; Hany T; Sulser T; Bachmann LM Eur Urol; 2013 Jul; 64(1):106-17. PubMed ID: 23628493 [TBL] [Abstract][Full Text] [Related]
2. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature. Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970 [TBL] [Abstract][Full Text] [Related]
3. Comparing the Staging/Restaging Performance of 68Ga-Labeled Prostate-Specific Membrane Antigen and 18F-Choline PET/CT in Prostate Cancer: A Systematic Review and Meta-analysis. Lin CY; Lee MT; Lin CL; Kao CH Clin Nucl Med; 2019 May; 44(5):365-376. PubMed ID: 30888999 [TBL] [Abstract][Full Text] [Related]
4. 18F-Fluoroethylcholine PET/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent. Tilki D; Reich O; Graser A; Hacker M; Silchinger J; Becker AJ; Khoder W; Bartenstein P; Stief CG; Loidl W; Seitz M Eur Urol; 2013 May; 63(5):792-6. PubMed ID: 22902037 [TBL] [Abstract][Full Text] [Related]
5. Choline PET or PET/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis. Evangelista L; Zattoni F; Guttilla A; Saladini G; Zattoni F; Colletti PM; Rubello D Clin Nucl Med; 2013 May; 38(5):305-14. PubMed ID: 23486334 [TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
7. von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806 [TBL] [Abstract][Full Text] [Related]
8. Utility of choline positron emission tomography/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysis. Evangelista L; Guttilla A; Zattoni F; Muzzio PC; Zattoni F Eur Urol; 2013 Jun; 63(6):1040-8. PubMed ID: 23036576 [TBL] [Abstract][Full Text] [Related]
9. State of the art of PET/CT with 11-choline and 18F-fluorocholine in the diagnosis and follow-up of localized and locally advanced prostate cancer. Vagnoni V; Brunocilla E; Bianchi L; Porreca A; Borghesi M; Pultrone CV; Angelo P; Chessa F; Ceci F; Mengoni F; Dababneh H; Castellucci P; Fanti S; Martorana G; Schiavina R Arch Esp Urol; 2015 Apr; 68(3):354-70. PubMed ID: 25948806 [TBL] [Abstract][Full Text] [Related]
10. Comparison of meta-analyses among elastosonography (ES) and positron emission tomography/computed tomography (PET/CT) imaging techniques in the application of prostate cancer diagnosis. Ouyang Q; Duan Z; Lei J; Jiao G Tumour Biol; 2016 Mar; 37(3):2999-3007. PubMed ID: 26415734 [TBL] [Abstract][Full Text] [Related]
11. The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer. Picchio M; Briganti A; Fanti S; Heidenreich A; Krause BJ; Messa C; Montorsi F; Reske SN; Thalmann GN Eur Urol; 2011 Jan; 59(1):51-60. PubMed ID: 20869161 [TBL] [Abstract][Full Text] [Related]
12. Clinical utility of (18)F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study. Rodado-Marina S; Coronado-Poggio M; García-Vicente AM; García-Garzón JR; Alonso-Farto JC; de la Jara AC; Maldonado-Suárez A; Rodríguez-Fernández A BJU Int; 2015 Jun; 115(6):874-83. PubMed ID: 25307619 [TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen kinetics parameters are predictive of positron emission tomography features worsening in patients with biochemical relapse after prostate cancer treatment with radical intent: Results from a longitudinal cohort study. Gacci M; Cai T; Siena G; Minervini A; Torshizi MF; Bartolini M; Giannì G; Saieva C; Ceroti M; Detti B; Livi L; Pupi A; Carini M Scand J Urol; 2014 Jun; 48(3):259-67. PubMed ID: 24255954 [TBL] [Abstract][Full Text] [Related]
15. [¹¹C]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy. Giovacchini G; Incerti E; Mapelli P; Kirienko M; Briganti A; Gandaglia G; Montorsi F; Gianolli L; Picchio M Eur J Nucl Med Mol Imaging; 2015 May; 42(6):877-84. PubMed ID: 25697127 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of choline PET/CT for the detection of bone metastasis in prostate cancer: A systematic review and meta-analysis. Guo Y; Wang L; Hu J; Feng D; Xu L PLoS One; 2018; 13(9):e0203400. PubMed ID: 30192819 [TBL] [Abstract][Full Text] [Related]
17. 18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients. Beheshti M; Imamovic L; Broinger G; Vali R; Waldenberger P; Stoiber F; Nader M; Gruy B; Janetschek G; Langsteger W Radiology; 2010 Mar; 254(3):925-33. PubMed ID: 20177103 [TBL] [Abstract][Full Text] [Related]
18. Restaging prostate cancer patients with biochemical failure with PET/CT and radiolabeled choline. Giovacchini G; Breeuwsma AJ Q J Nucl Med Mol Imaging; 2012 Aug; 56(4):354-66. PubMed ID: 23013665 [TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy. Giovacchini G; Picchio M; Parra RG; Briganti A; Gianolli L; Montorsi F; Messa C Clin Nucl Med; 2012 Apr; 37(4):325-31. PubMed ID: 22391699 [TBL] [Abstract][Full Text] [Related]
20. Impact of total PSA, PSA doubling time and PSA velocity on detection rates of 11C-Choline positron emission tomography in recurrent prostate cancer. Rybalov M; Breeuwsma AJ; Leliveld AM; Pruim J; Dierckx RA; de Jong IJ World J Urol; 2013 Apr; 31(2):319-23. PubMed ID: 22814886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]